Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy.

@article{Zarling2006IdentificationOC,
  title={Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy.},
  author={Angela L. Zarling and Joy M. Polefrone and Anne M. Evans and Leann M Mikesh and Jeffrey Shabanowitz and Sarah T Lewis and Victor H Engelhard and Donald F. Hunt},
  journal={Proceedings of the National Academy of Sciences of the United States of America},
  year={2006},
  volume={103 40},
  pages={14889-94}
}
Alterations in phosphorylation of cellular proteins are a hallmark of malignant transformation. Degradation of these phosphoproteins could generate cancer-specific class I MHC-associated phosphopeptides recognizable by CD8+ T lymphocytes. In a comparative analysis of phosphopeptides presented on the surface of melanoma, ovarian carcinoma, and B lymphoblastoid cells, we find 5 of 36 that are restricted to the solid tumors and common to both cancers. Differential presentation of these peptides… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
43 Extracted Citations
5 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 43 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-5 of 5 references

Im M U N O Lo G Y Ch Em Is Tr Y Se

  • S Ficarro, O Chertihin, +8 authors PE Visconti
  • J Biol Chem 278:11579–89. Zarling et al. PNAS…
  • 2003

Trends Cell Biol 12:104–107

  • JW Harper
  • 2002

Cancer Immunol Immunother

  • CL Slingluff, TA Colella, +7 authors C Oei
  • 2000

Melanoma Res 10:401–411

  • DJ Easty, DC Bennett
  • 2000

Hum Immunol

  • P Parham, FM Brodsky
  • 1981

Similar Papers

Loading similar papers…